Tianjin Tianyao Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TIANJIN TIANYAO, and what generic and branded alternatives to TIANJIN TIANYAO drugs are available?
TIANJIN TIANYAO has two approved drugs.
Drugs and US Patents for Tianjin Tianyao
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tianjin Tianyao | CELECOXIB | celecoxib | CAPSULE;ORAL | 207872-002 | Feb 25, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tianjin Tianyao | CELECOXIB | celecoxib | CAPSULE;ORAL | 207872-003 | Feb 25, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tianjin Tianyao | CELECOXIB | celecoxib | CAPSULE;ORAL | 207872-001 | Feb 25, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.